Women's Access and Provider Practices for the Case Management of Malaria during Pregnancy: A Systematic Review and Meta-Analysis

English version České info

Background:
WHO recommends prompt diagnosis and quinine plus clindamycin for treatment of uncomplicated malaria in the first trimester and artemisinin-based combination therapies in subsequent trimesters. We undertook a systematic review of women's access to and healthcare provider adherence to WHO case management policy for malaria in pregnant women.

Methods and Findings:
We searched the Malaria in Pregnancy Library, the Global Health Database, and the International Network for the Rational Use of Drugs Bibliography from 1 January 2006 to 3 April 2014, without language restriction. Data were appraised for quality and content. Frequencies of women's and healthcare providers' practices were explored using narrative synthesis and random effect meta-analysis. Barriers to women's access and providers' adherence to policy were explored by content analysis using NVivo. Determinants of women's access and providers' case management practices were extracted and compared across studies. We did not perform a meta-ethnography. Thirty-seven studies were included, conducted in Africa (30), Asia (4), Yemen (1), and Brazil (2). One- to three-quarters of women reported malaria episodes during pregnancy, of whom treatment was sought by >85%. Barriers to access among women included poor knowledge of drug safety, prohibitive costs, and self-treatment practices, used by 5%–40% of women. Determinants of women's treatment-seeking behaviour were education and previous experience of miscarriage and antenatal care. Healthcare provider reliance on clinical diagnosis and poor adherence to treatment policy, especially in first versus other trimesters (28%, 95% CI 14%–47%, versus 72%, 95% CI 39%–91%, p = 0.02), was consistently reported. Prescribing practices were driven by concerns over side effects and drug safety, patient preference, drug availability, and cost. Determinants of provider practices were access to training and facility type (public versus private). Findings were limited by the availability, quality, scope, and methodological inconsistencies of the included studies.

Conclusions:
A systematic assessment of the extent of substandard case management practices of malaria in pregnancy is required, as well as quality improvement interventions that reach all providers administering antimalarial drugs in the community. Pregnant women need access to information on which anti-malarial drugs are safe to use at different stages of pregnancy.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Women's Access and Provider Practices for the Case Management of Malaria during Pregnancy: A Systematic Review and Meta-Analysis. PLoS Med 11(8): e32767. doi:10.1371/journal.pmed.1001688
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001688

Souhrn

Zdroje

1. World Health Organization (2010) Guidelines for the treatment of malaria, second edition. Geneva: World Health Organization.

2. World Health Organization (2006) Guidelines for the treatment of malaria. Geneva: World Health Organization.

3. WardSA, SeveneEJ, HastingsIM, NostenF, McGreadyR (2007) Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis 7: 136–144.

4. Roll Back Malaria (2014) Global malaria action plan for a malaria-free world: Part II: the global strategy. 2. Overcoming malaria. Available: http://www.rollbackmalaria.org/gmap/2-2.html#. Accessed 20 May 2014.

5. HillJ, HoytJ, van EijkAM, D'Mello-GuyettL, Ter KuileFO, et al. (2013) Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med 10: e1001488.

6. van EijkAM, HillJ, PovallS, ReynoldsA, WongH, et al. (2013) The Malaria in Pregnancy Library: a bibliometric review. Malar J 11: 362.

7. EBSCO Information Services (2014) Global Health Database [database]. Available: http://www.ebscohost.com/corporate-research/global-health. Accessed 15 April 2014.

8. International Network for the Rational Use of Drugs (2014) INRUD Bibliography [database]. Available: http://www.inrud.org/Bibliographies/INRUD-Bibliography.cfm. Accessed 7 April 2014.

9. AdamT, HsuJ, de SavignyD, LavisJN, RottingenJA, et al. (2012) Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions? Health Policy Plan 27 (Suppl 4)iv9–iv19.

10. de SavignyD, WebsterJ, AgyepongIA, MwitaA, Bart-PlangeC, et al. (2012) Introducing vouchers for malaria prevention in Ghana and Tanzania: context and adoption of innovation in health systems. Health Policy Plan 27 (Suppl 4)iv32–iv43.

11. World Health Organization (2009) Systems thinking for health systems strengthening. Geneva: World Health Organization.

12. MaigaAS, DiakiteM, DiawareA, SangoHA, CoulibalyCO (2010) [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine for pregnant women in Selingue in Mali.]. Mali Med 25: 41–48.

13. Deeks JJ, Higgins JPT, Altman DG, editors (2009) Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester (UK): The Cochrane Collaboration.

14. SabinLL, RizalA, BrooksMI, SinghMP, TuchmanJ, et al. (2010) Attitudes, knowledge, and practices regarding malaria prevention and treatment among pregnant women in Eastern India. Am J Trop Med Hyg 82: 1010–1016.

15. WylieBJ, HashmiAH, SinghN, SinghMP, TuchmanJ, et al. (2010) Availability and utilization of malaria prevention strategies in pregnancy in eastern India. BMC Public Health 10: 557.

16. Population Services International Research and Metrics (2007) Cambodia 2007: TRaC study exploring the determinants of malaria health care provision among private providers in malaria endemic areas—first round. Washington (District of Columbia): Population Services International.

17. Tawfik L (2006) Mosquitoes, malaria and malarine: a qualitative study on malaria drug use in Cambodia. Arlington (Virginia): US Agency for International Development.

18. Bin GhouthAS (2013) Availability and prescription practice of anti-malaria drugs in the private health sector in Yemen. J Infect Dev Ctries 7: 404–412.

19. LuzTCB, MirandaES, FreitasLF, Osorio-de-CastroCGS (2013) Prescriptions for uncomplicated malaria treatment among pregnant women in the Brazilian Amazon: evidences from the Mafalda Project. Rev Bras Epidemiol 16: 409–419.

20. LuzTC, Suarez-MutisC, MirandaS, MoritzF, FreitasF, et al. (2013) Uncomplicated malaria among pregnant women in the Brazilian Amazon: local barriers to prompt and effective case management. Acta Trop 125: 137–142.

21. PellC, MeñacaA, AfrahNA, Manda-TaylorL, ChatioS, et al. (2013) Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi. Malar J 12: 427.

22. LaunialaA, HonkasaloML (2010) Malaria, danger, and risk perceptions among the Yao in rural Malawi. Med Anthropol Q 24: 399–420.

23. Smith PaintainLA, JonesC, AdjeiRO, AntwiGD, AfrahNA, et al. (2010) Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J 9: 18.

24. MbachuCO, OnwujekweOE, UzochukwuBS, UchegbuE, OranubaJ, et al. (2012) Examining equity in access to long-lasting insecticide nets and artemisinin-based combination therapy in Anambra state, Nigeria. BMC Public Health 12: 315.

25. SangaréLR, WeissNS, BrentlingerPE, RichardsonBA, StaedkeSG, et al. (2011) Patterns of anti-malarial drug treatment among pregnant women in Uganda. Malar J 10: 152.

26. HenryOJ, LagoroKD, OrachCG (2012) Prevalence of malaria and treatment seeking behaviours among pregnant women in postconflict internally displaced persons' camps in Gulu District. ISRN Public Health 2012: 164935 doi:10.5402/2012/164935

27. EnatoEF, MensPF, OkhamafeAO, OkpereEE, PogosonE, et al. (2009) Plasmodium falciparum malaria in pregnancy: prevalence of peripheral parasitaemia, anaemia and malaria care-seeking behaviour among pregnant women attending two antenatal clinics in Edo State, Nigeria. J Obstet Gynaecol 29: 301–306.

28. ObiecheAO, EnatoEF, AndeAB (2013) Patterns of treatment of reported malaria cases during pregnancy in a Nigerian hospital. Scand J Infect Dis 45: 849–854.

29. OnwujekweO, OnwujekweOO, SoremekunR (2013) Chemotherapy and chemoprophylaxis of malaria in pregnancy in private and public facilities: perceptions and use by pregnant women in Enugu State, Nigeria. Gend Behav 11: 5688–5697.

30. Kwansa-BentumB, AyiI, SuzukiT, OtchereJ, KumagaiT, et al. (2011) Administrative practices of health professionals and use of artesunate-amodiaquine by community members for treating uncomplicated malaria in southern Ghana: implications for artemisinin-based combination therapy deployment. Trop Med Int Health 16: 1215–1224.

31. AdamI, OmerEsM, SalihA, KhamisA, MalikEM (2008) Perceptions of the causes of malaria and its complications, treatment and prevention among midwives and pregnant women of Eastern Sudan. J Public Health 16: 129–132.

32. KarunamoorthiK, DebochB, TafereY (2010) Knowledge and practice concerning malaria, insecticide-treated net (ITN) utilization and antimalarial treatment among pregnant women attending specialist antenatal clinics. J Public Health 18: 559–566.

33. Sam-WoboSO, AkinboroyeT, AnosikeJC, AdewaleB (2008) Knowledge and practices on malaria treatment measures among pregnant women in Abeokuta, Nigeria. Tanzan J Health Res 10: 226–231.

34. MbonyeAK, BirungiJ, YanowS, MagnussenP (2013) Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics. BMC Infect Dis 13: 237.

35. KamuhabwaAR, MnyusiwallaF (2011) Rational dispensing and use of artemether-lumefantrine during pregnancy in Dar es Salaam, Tanzania. Tanzan J Health Res 13.

36. ManirakizaA, SoulaG, LaganierR, KlementE, DjalleD, et al. (2011) Pattern of the antimalarials prescription during pregnancy in Bangui, Central African Republic. Malar Res Treat 2011: 414510.

37. Omo-AghojaLO, AghojaCO, OghagbonK, Omo-AghojaVW, EsumeC (2008) Prevention and treatment of malaria in pregnancy in Nigeria: obstetrician's knowledge of guidelines and policy changes-a call for action. J Chin Clin Med 3: 114–120.

38. UmarMT, ChikaA, JimohAO (2011) Compliance of primary health care providers to recommendation of artemesinin-based combination therapy in the treatment of uncomplicated malaria in selected primary health care centres in Sokoto, north western Nigeria. Int J Trop Med 6: 70–72.

39. OnwujekweOC, SoremekunRO, UzochukwuB, ShuE, OnwujekweO (2012) Patterns of case management and chemoprevention for malaria-in-pregnancy by public and private sector health providers in Enugu state, Nigeria. BMC Res Notes 5: 211.

40. OkoroRN, NwambuJO (2012) Evaluation of physicians' prescribing patterns of antimalarial drugs during pregnancy at the obstetrics and gynaecology department of a teaching hospital in Maduguri, Borno State, Nigeria. Int J Pharm Biomed Sci 3: 39–46.

41. Kiningu DK (2013) Factors influencing the use of evidence based guidelines in the management of malaria in pregnancy among health workers at Garissa Provincial Hospital, Kenya [Master's thesis]. Nairobi: School of Public Health, University of Nairobi. Available: http://erepository.uonbi.ac.ke:8080/xmlui/bitstream/handle/11295/59598/Factors%20Influencing%20The%20Use%20Of%20Evidence%20Based%20Guidelines%20in%20the%20Management%20of%20Malaria%20in%20Pregnancy%20Among%20Health%20Workers%20at%20Garissa%20Provincial%20Hospital%20Kenya.pdf?sequence=3. Accessed 7 July 2014

42. Kalilani-PhiriLV, LunguD, CoghlanR (2011) Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals. Malar J 10: 279.

43. HarrisonN, OlufunlayoT, AgomoC (2012) Utilization of the current national antimalarial treatment guidelines among doctors in army hospitals in Lagos, Nigeria. Open J Prev Med 2: 390–393.

44. EnatoEFO, ErihriRE (2012) Knowledge, perception and management of malaria in pregnancy by traditional birth attendants in Benin City. J Pharm Allied Sci 8: 1292–1297.

45. StangelandT, AlelePE, KatuuraE, LyeKA (2011) Plants used to treat malaria in Nyakayojo sub-county, western Uganda. J Ethnopharmacol 137: 154–166.

46. OkontaPI (2011) How many physicians prescribe quinine for the treatment of malaria in the first trimester of pregnancy? Ebonyi Med J 10: 105–111.

47. Smith PaintainL, AntwiGD, JonesC, AmoakoE, AdjeiRO, et al. (2011) Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability. PLoS ONE 6: e24035.

48. Malawi Ministry of Health (2008) Republic of Malawi Ministry of Health national malaria control program supervision report for monitoring ACT and malaria control activities. Lilongwe: Malawi Ministry of Health.

49. Uganda Ministry of Health (2005) National policy on malaria treatment 2005. Kampala: Uganda Ministry of Health.

50. Tanzania Ministry of Health and Social Welfare (2006) National guidelines for malaria diagnosis and treatment 2005. Dar es Salaam: Tanzania Ministry of Health and Social Welfare.

51. MinyaliwaC, BandaweC, MwaleRJ (2012) How much do Blantyre dispensers in hospital and community pharmacies know about the new malaria treatment guidelines? Malawi Med J 24: 1–4.

52. MbonyeAK, MagnussenP (2010) Symptom-based diagnosis of malaria and its implication on antimalarial drug use in pregnancy in central Uganda: results from a community trial. Int J Adolesc Med Health 22: 257–262.

53. PellC, StrausL, AndrewEVW, MeñacaA, PoolR (2011) Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS ONE 6: e22452.

54. FinlaysonK, DowneS (2013) Why do women not use antenatal services in low- and middle-income countries? A meta-synthesis of qualitative studies. PLoS Med 10: e1001373.

55. JohnsonA, GossA, BeckermanJ, CastroA (2012) Hidden costs: the direct and indirect impact of user fees on access to malaria treatment and primary care in Mali. Soc Sci Med 75: 1786–1792.

56. PerkinsM, BrazierE, ThemmenE, BassaneB, DialloD, et al. (2009) Out-of-pocket costs for facility-based maternity care in three African countries. Health Policy Plan 24: 289–300.

57. WorrallE, MorelC, YeungS, BorghiJ, WebsterJ, et al. (2007) The economics of malaria in pregnancy—a review of the evidence and research priorities. Lancet Infect Dis 7: 156–168.

58. BardajiA, SigauqueB, BruniL, RomagosaC, SanzS, et al. (2008) Clinical malaria in African pregnant women. Malar J 7: 27.

59. BhagatK, NyazemaN (2001) General practitioners and clinical guidelines. East Afr Med J 78: 30–34.

60. CrawleyJ, HillJ, YarteyJ, RobaloM, SerufiliraA, et al. (2007) From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis 7: 145–155.

61. DellicourS, ter KuileFO, StergachisA (2008) Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. PLoS Med 5: e187.

62. Bloland P (2001) Drug resistance in malaria. WHO/CDS/CSR/DRS/2001.4. Geneva: World Health Organization.

63. World Health Organization (2005.) Global report on antimalarial drug efficacy and drug resistance: 2000–2010. Geneva: World Health Organization.

64. FairhurstRM, NayyarGM, BremanJG, HallettR, VennerstromJL, et al. (2012) Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg 87: 231–241.